RNA Q3 2023 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+13.5% YoY

Gross Profit

-$45M-1593.2% margin

Operating Income

-$59M-2080.4% margin

Net Income

-$52M-1858.0% margin

EPS (Diluted)

$-0.71

QoQ Revenue Growth

+21.7%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$38M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$573M

Total Liabilities

$56M

Stockholders' Equity

$517M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+13.5%
Gross Profit	-$45M	-$35M	-28.9%
Operating Income	-$59M	-$45M	-30.5%
Net Income	-$52M	-$44M	-20.1%